Pouyiourou, Maria http://orcid.org/0000-0001-9296-3784
Kraft, Bianca N.
Wohlfromm, Timothy
Stahl, Michael
Kubuschok, Boris http://orcid.org/0000-0001-5000-2328
Löffler, Harald
Hacker, Ulrich T.
Hübner, Gerdt
Weiss, Lena
Bitzer, Michael http://orcid.org/0000-0002-4463-8263
Ernst, Thomas http://orcid.org/0000-0003-2147-489X
Schütt, Philipp
Hielscher, Thomas http://orcid.org/0000-0003-1277-310X
Delorme, Stefan http://orcid.org/0000-0002-1000-2582
Kirchner, Martina
Kazdal, Daniel
Ball, Markus http://orcid.org/0000-0002-2312-8360
Kluck, Klaus http://orcid.org/0009-0001-1000-8052
Stenzinger, Albrecht http://orcid.org/0000-0003-1001-103X
Bochtler, Tilmann
Krämer, Alwin http://orcid.org/0000-0001-8232-9982
Funding for this research was provided by:
Bristol-Myers Squibb Company | Bristol-Myers Squibb Canada
Article History
Received: 5 April 2023
Accepted: 10 October 2023
First Online: 24 October 2023
Competing interests
: M.S. received consultation fees and honoraria from BMS. B.K. received grants/research support from Roche, Morphosys, MSD and Hexal, and honoraria from Roche. U.T.H. received grants/research support from Celgene and Roche, and honoraria from Roche, Servier, Novartis and Merck Serono. G.H. received consultation fees from Roche and AstraZeneca, and honoraria from Roche, Amgen, Pierre-Fabre, AstraZeneca, Alexion, Servier, Octapharma, Abbvie, GSK and Beigene. L.W. received honoraria from Roche and Servier and travel support from Amgen. M.B. received consultation fees from Roche, Incyte, Bayer, MSD and Ipsen. A.S. received grants/research support from Bayer, BMS, Chugai and Incyte, and consultation fees/honoraria from Aignostics, Amgen, Astra Zeneca, Bayer, BMS, Eli Lilly, Illumina, Incyte, Janssen, MSD, Novartis, Pfizer, Qlucore, Roche, Seattle Genetics, Takeda and Thermo Fisher. T.B. has worked as a study oncologist for the CUPISCO trial, which is sponsored by Roche and has received reimbursement for study-related travels as well as remuneration for his work as a study oncologist for the benefit of his employer. A.K. received consultation fees and honoraria from Roche and grants/research support from BMS and Molecular Health. All remaining authors declare no competing interests.